Search results
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.32%
Investing.com· 19 hours agoU.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.32%
Shah Capital seeks board overhaul at Novavax By Investing.com
Investing.com· 4 days agoShah Capital Management, a major shareholder in Novavax Inc. (NASDAQ:NVAX), has publicly expressed...
Stocks Pause On Dismal Consumer Confidence; Yields, Dollar Rise As Inflation Expectations Kick...
Benzinga via Yahoo Finance· 5 hours agoEditor’s note: This story has been updated to correct an error in the price action of Charter...
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.32% By Investing.com
Investing.com· 4 hours agoU.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.32%
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.32% By Investing.com
Investing.com· 4 hours agoU.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.32%
Crude Oil Down 1%; Sweetgreen Shares Spike Higher - Macrogenics (NASDAQ:MGNX)
Benzinga· 6 hours agoHowever, markets were expecting a reading of 76. Equities Trading UP Loading... Loading... Novavax, Inc . NVAX shares shot up 99% to $8.91 after the company ...
Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19:...
Benzinga· 2 days agoElon Musk has come off as a flagbearer of the mRNA technology, which is seen holding out a lot of...
Novavax's top shareholder Shah Capital ramps up efforts for board shakeup
Reuters· 4 days ago, opens new tab shareholders to vote against the re-election of three directors and proposals...
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day...
Benzinga· 7 hours agoShares of Diodes Incorporated DIOD fell sharply during Friday's session after the company reported...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 17 hours agoNovavax Reports First Quarter 2024 Financial Results and Operational Highlights PR Newswire GAITHERSBURG, Md., May 10, 2024 Announces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza